Dear colleagues,   The new WHO’s vaccine safety virtual learning ecosystem offers 4 WHO certified courses on vaccine safety and AEFI namely 1. Vaccine Safety Basics 2. AEFI data management basics 3. AEFI investigation 4. AEFI causality assessment These 4 courses are available on the ...

If a recipient received Influenza (Flu) Vaccine can receive COVID19 Vaccine next day more precisely AstraZeneca...

This week, the University of Oslo and the HISP network will host webinars on the DHIS2 COVID-19 Vaccine Delivery Toolkit for our French-, Portuguese- and Spanish-speaking audiences. These events are free to attend, and registration is open via the links below:French: Tuesday, 16 Feb 14:30 UTC. ...

Respected Sir/Madam   Greetings from IIHMR UNIVERSITY, JAIPUR , INDIA I take immense pleasure to share with you that School of Pharmaceutical Management; The IIHMR University is organizing a 05 days International training programme on “Logistics Management of Vaccines with special focus on S...

The second edition of the user manual for the revised WHO classification for the causality assessment of an adverse event following immunization (AEFI) was developed by the WHO with support from the Global Advisory Committee for Vaccine Safety (GACVS). This was based on the findings of a scientific ...

Goodday colleagues, I am developing a post-graduate research proposal for submission in an academic institution to improve service delivery and continous quality improvement. The topic isTHE KNOWLEDGE (understanding and perception) OF & REPORTING PATTERN OF ADVERSE EVENTS FOLLOWING IMMUNIZATION (AE...

Hello All, In the website for WHO PQ vaccines BCG and Yellow Fever are the two vaccines which have multi dose preparations packaged in ampoules. As soon as we open a mulit-dose ampoule and administer the first dose, we are leaving the remining doses in the ampoule exposed to environment (very often...

Excerpts from a discussion on another forum about adverse events following immunization (AEFI) data collection. Dhruv wrote: A wise option. Why don't we develop a cellphone-based VAERS? Prabir wrote: See http://www.slideshare.net/prabirkc/sms-based-death-reporting which has to do with a simi...

Cross-posted from the January 2012 issue of GIN with thanks. 31/01/2012 from Madhav Balakrishnan, WHO HQ The Global Network for Post-marketing Surveillance (PMS) of Vaccines was established by WHO in early 2008 with a primary objective to monitor the safety of WHO prequalified vaccines supplied thr...